NCT07582913 Manual Versus Autoflow Ventilation During Anesthesia Inductıon in Geriatric Patients
| NCT ID | NCT07582913 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Cerebral Oxygenation |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2026-05-13 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2026-05-13 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to compare the effects of manual ventilation and AutoFlow ventilation, administered during the induction of general anesthesia, on cerebral (s-rSO₂) and peripheral (somatic) oxygenation (p-rSO₂) in geriatric patients.
Eligibility Criteria
Inclusion Criteria: * Patients aged 65 years and older. * Patients scheduled to undergo elective surgery requiring endotracheal intubation under general anesthesia. * Patients with an American Society of Anesthesiologists (ASA) physical status of I, II, or III. * Volunteer patients who are willing to participate and provide written informed consent. Exclusion Criteria: * Patients with severe heart failure or severe pulmonary disease. * Patients with a presence or history of brain tumors or cerebrovascular accidents (CVA/stroke). * Patients with impaired cooperation or cognitive dysfunction (e.g., dementia, delirium, Alzheimer's disease). * Patients with a known history or preoperative prediction of a difficult airway. * Patients with a known allergy to the monitoring sensor materials.
Contact & Investigator
EYÜP HORASANLI, Professor
STUDY DIRECTOR
Ankara Bilkent City Hospital Department of Anesthesiology and Reanimation
Frequently Asked Questions
Who can join the NCT07582913 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Cerebral Oxygenation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07582913 currently recruiting?
Yes, NCT07582913 is actively recruiting participants. Contact the research team at fatmagulgunkilicaslan@gmail.com for enrollment information.
Where is the NCT07582913 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07582913 clinical trial?
NCT07582913 is sponsored by Ankara City Hospital Bilkent. The principal investigator is EYÜP HORASANLI, Professor at Ankara Bilkent City Hospital Department of Anesthesiology and Reanimation. The trial plans to enroll 106 participants.